Qumis | $2,200,000 | (Jan 22, 2025)
Zynap | $5,937,902 | (Jan 22, 2025)
Belfry | $12,000,000 | (Jan 22, 2025)
Cagent Vascular
United States
- Wayne, PA
- 22/02/2024
- Series C
- $30,000,000
Cagent Vascular (Wayne, PA) has developed and commercialized its novel angioplasty balloon with Serration Technology to treat blocked arteries in the leg or Peripheral Artery Disease (PAD) and Chronic Limb Threatening Ischemia (CLTI). The Serranator PTA Serration Balloon Catheter is the first and only angioplasty balloon with serration technology
- Industry Medical Equipment Manufacturing
- Website https://cagentvascular.com/
- LinkedIn https://www.linkedin.com/company/cagent-vascular/
Related People
Carol BurnsCo Founder
United States -
Wayne, Pennsylvania
CEO, Serial Entrepreneur, Bold & Strategic, Deep Cardiovascular Knowledge, Tireless Energy, Proven Track Record
Experienced in all phases of medical device development from early stage proof of concept to commercialization. Cardiovascular devices are my passion. I like the fast pace of the start-up world! My past experience, industry relationships and clinical knowledge help me identify technologies that have the best chance for success.
I'm committed to developing devices that will improve patient's lives, that physicians will want to use and that investors will realize a return for their investment.
Gravity(US) | $13,000,000 | (Jan 22, 2025)
LeapXpert | $20,000,000 | (Jan 22, 2025)
BPR Hub | $2,600,000 | (Jan 22, 2025)
NovoLINC | Undisclosed Amount | (Jan 22, 2025)
IntusCare | $11,500,000 | (Jan 21, 2025)
ecoplanet | $16,571,680 | (Jan 21, 2025)
Sereact | $25,894,660 | (Jan 21, 2025)
Fundment | $55,157,175 | (Jan 21, 2025)
Men In Blazers Media Network | $150,000,000 | (Jan 21, 2025)